Enter inventor name

Kathryn Jane Smith

USPTO Granted Patents = 13 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 631(Granted Patents)

Location History:

Herts, GB (2002)
Bishop's Stortford, GB (2001 - 2004)
Hertfordshire, GB (2004 - 2006)
Stevenage, GB (2001 - 2008)

Company Filing History:

7 out of 2,198

Smithkline Beecham Corporation

Years Active: 2001-2008

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7432289 - 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors (2008-10-07),

2. 7425555 - Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors (2008-09-16),

3. 7208629 - 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors (2007-04-24),

4. 7166623 - 2'-Methyl-5′-(1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors (2007-01-23),

5. 7109333 - Heterocyclic compounds (2006-09-19),

6. 6828320 - Heterocyclic compounds (2004-12-07),

7. 6727256 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2004-04-27),

8. 6723726 - Protein tyrosine kinase inhibitors (2004-04-20),

9. 6713485 - Heterocyclic compounds (2004-03-30),

10. 6391874 - Fused heterocyclic compounds as protein tyrosine kinase inhibitors (2002-05-21),

11. 6207669 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2001-03-27),

12. 6174889 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2001-01-16),

13. 6169091 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2001-01-02),

Title: **Kathryn Jane Smith: Innovator in Pharmaceutical Patents**

Introduction

Kathryn Jane Smith, an inventive mind from Bishops Stortford, GB, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 13 patents, her work primarily focuses on developing compounds that serve as inhibitors for critical biological pathways.

Latest Patents

Among Kathryn's latest innovations are the patents titled "5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors," as well as "Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors." These compounds, denoted by formula (I), are of great interest due to their potential applications in treating conditions associated with p38 kinase activity, an enzyme implicated in various disease states.

Career Highlights

Throughout her career, Kathryn has contributed her expertise by working with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Glaxo Wellcome Inc. Her dedication to innovation in drug development has further solidified her reputation as a leading inventor in her field.

Collaborations

In her journey, Kathryn has collaborated with notable figures such as George Stuart Cockerill and Stephen Barry Guntrip. These collaborations have played a crucial role in enhancing her research and driving forward the development of her innovative pharmaceutical compounds.

Conclusion

Kathryn Jane Smith's contributions to the pharmaceutical industry demonstrate her commitment to advancing medical science through innovative inventions. With her extensive experience and impressive patent portfolio, she stands out as a prominent figure whose work is paving the way for new therapeutic avenues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com